暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
暂无内容
暂无数据
暂无数据
暂无数据
快讯 | ExcelFin收购公司宣布增加延期付款
Moomoo 24/704/22 11:30 (美东)
快讯 | ExcelFin 收购公司宣布延期提案延期 30 天
Moomoo 24/704/11 16:30 (美东)
对ExcelFin的收购,贝尔德:更新的交易条款在一定程度上是由贝尔德医疗的2023年业绩低于预期推动的
对ExcelFin的收购,贝尔德:更新的交易条款在一定程度上是由贝尔德医疗的2023年业绩低于预期推动的
道琼斯03/12 07:07 (美东)
贝尔德医疗同意以交易方式收到的30%的股份,以12.50美元的交易价格获利
贝尔德医疗同意以交易方式收到的30%的股份,以12.50美元的交易价格获利
道琼斯03/12 07:06 (美东)
贝尔德医疗预计将在收盘后在纳斯达克上市,股票代码为BDMD
贝尔德医疗预计将在收盘后在纳斯达克上市,股票代码为BDMD
道琼斯03/12 07:06 (美东)
ExcelFin收购,贝尔德:1500万美元的最低现金条件已免除 >XFIN
ExcelFin收购,贝尔德:1500万美元的最低现金条件已免除 >XFIN
道琼斯03/12 07:06 (美东)
暂无数据
暂无数据
JESSE JAMES8832 : hmmm nice find i like this one looks like a good value stock
Trytosaveabit楼主 JESSE JAMES8832: Thanks! I think so also at least what I’m finding so far. I believe it’s going to be more of a bit longer hold than I usually do? But yeah I’m kinda digging it! GL hope you have a killer day my man
JESSE JAMES8832 : only thing i see is that if you compare it too alot in its class they dont seem to climb much higher than 11 i guess.!?
Trytosaveabit楼主 JESSE JAMES8832: Yeah! But I’m hoping as the news of the availability of this new thyroid treatment gets out that they will start selling the hell out of it! It’s pretty amazing how they now can treat thyroid disease and still be able to save the thyroid! That should be pretty big?
Trytosaveabit楼主 JESSE JAMES8832: Oh and it looks like from what I’m seeing so far. They still have to complete the merger? The business combination was extended again, they now have at the latest April? But now I think that will happen quicker? Then that’s when I believe it could really get interesting? JMO though! Hehehe
查看更多评论...